Content about Sanofi Pasteur

January 14, 2013

Enough flu vaccines to go around - just not everywhere at once

Amid an unusually strong flu season that the Centers for Disease Control and Prevention has called an epidemic, supplies of flu vaccines are running low, and some people hoping to get immunized are having trouble finding them.

October 22, 2012

Sanofi Pasteur presents influenza vaccine trial data

Sanofi Pasteur announced Monday the presentation of three clinical trials of an experimental influenza vaccine.

SWIFTWATER, Pa. — Sanofi Pasteur announced Monday the presentation of three clinical trials of an experimental influenza vaccine.

October 18, 2012

Sanofi Pasteur seeks to expand seasonal flu protection from three influenza strains to four

Sanofi Pasteur on Thursday announced it has filed for approval of a four-strain flu shot to the Food and Drug Administration.

SWIFTWATER, Pa. — Sanofi Pasteur on Thursday announced it has filed for approval of a four-strain flu shot to the Food and Drug Administration. An action date is anticipated in the second quarter of 2013.

October 9, 2012

Q&A: Campaigning  against the flu

Sanofi Pasteur, the vaccines division of French drug maker Sanofi, recently unveiled an effort to promote flu vaccinations that includes advertising and celebrity endorsements. DSN had the opportunity to talk to Sanofi Pasteur director of U.S. public relations and communications Michael Szumera about the campaign.

Flu vaccinations have received a lot of attention lately, and that’s no surprise, considering the Centers for Disease Control and Prevention’s recommendation that everyone ages 6 months and older get yearly vaccinations, not to mention the H1N1 pandemic flu scare.

October 5, 2012

Sanofi to visit San Francisco Walgreens on the next stop of its VacciNation Tour

Sanofi Pasteur will bring its Fluzone Intradermal Vaccine Coop de Quill VacciNation Tour to a San Francisco Walgreens on Oct. 6 as part of its cross-country efforts to raise awareness about the seriousness of influenza and the various vaccine options that are available for adults 18 to 64 years of age this flu season.

SWIFTWATER, Pa. — Sanofi Pasteur will bring its Fluzone Intradermal Vaccine Coop de Quill VacciNation Tour to a San Francisco Walgreens on Oct. 6 as part of its cross-country efforts to raise awareness about the seriousness of influenza and the various vaccine options that are available for adults 18 to 64 years of age this flu season.

September 24, 2012

Sanofi Pasteur hosts flu shot tour at Seattle Walgreens

Sanofi Pasteur is bringing its Fluzone Intradermal Vaccine Coop de Quill VacciNation Tour to Seattle Monday as part of its cross-country efforts to raise awareness about the seriousness of influenza and the various vaccine options that are available for adults 18 through 64 years old this flu season.

SWIFTWATER, Pa. — Sanofi Pasteur is bringing its Fluzone Intradermal Vaccine Coop de Quill VacciNation Tour to Seattle Monday as part of its cross-country efforts to raise awareness about the seriousness of influenza and the various vaccine options that are available for adults 18 through 64 years old this flu season.

In an effort to help improve flu immunization rates, Sanofi Pasteur's Fluzone Intradermal Vaccine Coop de Quill VacciNation Tour will visit the Kirkland Walgreens for a flu clinic event.

September 18, 2012

'Scrubs' actress hired as spokeswoman for flu vaccination campaign

Just days after Sanofi Pasteur's hiring of actor Chris O'Donnell as a celebrity spokesman for its flu vaccination campaign, the American Lung Association has hired actress Sarah Chalke for its campaign, for which it is also collaborating with Sanofi Pasteur.

WASHINGTON — Just days after Sanofi Pasteur's hiring of actor Chris O'Donnell as a celebrity spokesman for its flu vaccination campaign, the American Lung Association has hired actress Sarah Chalke for its campaign, for which it is also collaborating with Sanofi Pasteur.

The American Lung Association announced the enlistment of Chalke for its "Faces of Influenza" initiative to promote flu immunizations. Chalke, a cast member of the show Scrubs and a mother, will be the spokeswoman for the campaign during the 2012-2013 season.

September 13, 2012

Sanofi Pasteur enlists actor Chris O'Donnell in flu vaccine campaign

The vaccines division of French drug maker Sanofi has signed a deal with actor Chris O'Donnell to promote its flu vaccination products, the company said.

SWIFTWATER, Pa. — The vaccines division of French drug maker Sanofi has signed a deal with actor Chris O'Donnell to promote its flu vaccination products, the company said.

Sanofi Pasteur's campaign includes an effort to build awareness of influenza and vaccine options, including the company's Fluzone Intradermal vaccine, for adults through the age of 65 years. O'Donnell has appeared in such movies as "Fried Green Tomatoes" and "Kinsey," and more recently in such television shows as "NCIS: Los Angeles."

August 20, 2012

Sanofi Pasteur announces availability of Sklice head lice lotion

Sanofi's vaccine's division has launched a new treatment for head lice, the company said Monday.

SWIFTWATER, Pa. — Sanofi's vaccine's division has launched a new treatment for head lice, the company said Monday.

Sanofi Pasteur announced the availability of Sklice (ivermectin) lotion in the 0.5% strength. The drug is approved for patients ages 6 months and older.

The company said head lice cases have increased rapidly in the United States, affecting between 6 million and 12 million children ages 3 to 11 years each year.

July 16, 2012

Sanofi Pasteur begins shipping Fluzone in U.S. for 2012-2013 season

Sanofi Pasteur has begun shipping the first lots of its influenza vaccine for the 2012-2013 season.

SWIFTWATER, Pa. — Sanofi Pasteur has begun shipping the first lots of its influenza vaccine for the 2012-2013 season.

October 21, 2011

Study: Fluzone High-Dose works well in senior population

Sanofi Pasteur, the vaccines division of Sanofi, released data from a new study examining the ability of its Fluzone High-Dose vaccine to provoke an immune response in elderly and younger adults, compared with a standard dose of Fluzone vaccine.

SWIFTWATER, Pa. — Sanofi Pasteur, the vaccines division of Sanofi, released data from a new study examining the ability of its Fluzone High-Dose vaccine to provoke an immune response in elderly and younger adults, compared with a standard dose of Fluzone vaccine.

"The results further support the immunogenicity advantages of Fluzone High-Dose vaccine as compared to Fluzone vaccine, the standard dose comparator, in seniors 65 years of age and older," stated Peter Tsang, director clinical development, Sanofi Pasteur.

October 18, 2011

HDMA names six new directors; ABC's Neu appointed vice chair

The Healthcare Distribution Management Association on Tuesday named six new members to its board of directors.

ARLINGTON, Va. — The Healthcare Distribution Management Association on Tuesday named six new members to its board of directors — Maria Burns, Burlington Drug Co. VP and corporate secretart; Gregory Drew, Value Drug Co. president; Terrance Haas, Harvard Drug Group CEO; David Neu, AmerisourceBergen president; Dale Smith, H. D. Smith chairman and CEO; and Albert Thomas, senior director and general manager of VaxServe, a Sanofi Pasteur company.

September 28, 2011

Sanofi supports flu shot awareness program targeting seniors

Sanofi Pasteur on Wednesday launched an awareness campaign to inform Florida residents ages 65 years and older about the importance of influenza protection and the key role vaccination plays in helping to improve the body's immune response against the virus.

ORLANDO, Fla. — Sanofi Pasteur on Wednesday launched an awareness campaign to inform Florida residents ages 65 years and older about the importance of influenza protection and the key role vaccination plays in helping to improve the body's immune response against the virus.

Adults 65 years of age and older typically are the hardest hit by influenza. This new program, called Influenza Immunization for You, urges older adults to talk to their healthcare provider about vaccine options. Florida Hospital Medical Group is spearheading the initiative in the region.

August 30, 2011

Bartell offers flu vaccines

Regional retail pharmacy chain Bartell Drugs has launched its flu vaccination campaign, the Seattle-based company said Tuesday.

SEATTLE — Regional retail pharmacy chain Bartell Drugs has launched its flu vaccination campaign, the Seattle-based company said Tuesday.

Bartell said it would offer a full schedule of in-store vaccinations for individuals on a walk-in basis and a program servicing area businesses. The "in-the-workplace" vaccination program, now in its fifth year, serves businesses with 25 or more employees.

In addition to regular vaccines, the chain is offering Sanofi Pasteur's Fluzone High-Dose vaccine designed for patients 65 and older.

August 4, 2011

NASN, Sanofi Pasteur team up to raise awareness of meningitis

Meningococcal meningitis is rare but can kill preteens and teenagers in as little as a day. Yet many kids still engage in behaviors that put them at risk of contracting the disease despite not being vaccinated.

NEW YORK — Meningococcal meningitis is rare but can kill preteens and teenagers in as little as a day. Yet many kids still engage in behaviors that put them at risk of contracting the disease despite not being vaccinated.

July 19, 2011

Six drug makers OKed to produce flu vaccines

The Food and Drug Administration has approved a new influenza vaccine formulation for the 2011-2012 flu season, the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new influenza vaccine formulation for the 2011-2012 flu season, the agency said Monday.

The FDA said six manufacturers are licensed to produce vaccines. These include GlaxoSmithKline Biologicals, manufacturing Fluarix; CSL Limited, manufacturing Afluria; ID Biomedical, manufacturing FluLaval; MedImmune Vaccines, manufacturing FluMist; Novartis Vaccines and Diagnostics, manufacturing Fluvirin; and Sanofi Pasteur, manufacturing Fluzone.

July 18, 2011

Sanofi begins shipping flu vaccine for 2011-2012 season

Sanofi Pasteur, the vaccines division of Sanofi, on Monday announced that it has begun shipping its 2011-2012 Fluzone influenza virus vaccine in the United States.

SWIFTWATER, Pa. — Sanofi Pasteur, the vaccines division of Sanofi, on Monday announced that it has begun shipping its 2011-2012 Fluzone influenza virus vaccine in the United States. This shipment represents the first of approximately 70 million doses of seasonal influenza vaccine the company plans to deliver to the United States in the upcoming season.

June 6, 2011

Sanofi Pasteur donates tetanus-containing vaccine doses to storm victims

The vaccines division of drug maker Sanofi donated vaccine doses on behalf of the Jeff Gordon Children's Foundation to Direct Relief International, which will aid victims of the recent storms in the Southeast and Midwest.

SWIFTWATER, Pa. — The vaccines division of drug maker Sanofi donated vaccine doses on behalf of the Jeff Gordon Children's Foundation to Direct Relief International, which will aid victims of the recent storms in the Southeast and Midwest.

May 10, 2011

FDA OKs Sanofi Pasteur's Fluzone Intradermal

Sanofi’s vaccines division has won Food and Drug Administration approval for a vaccine designed for injection into the skin, the company said Tuesday.

SWIFTWATER, Pa. — Sanofi’s vaccines division has won Food and Drug Administration approval for a vaccine designed for injection into the skin, the company said Tuesday.

Sanofi Pasteur announced the FDA approval of Fluzone Intradermal (influenza virus vaccine), which injects the vaccine into the skin via a short, fine needle, also known as a microinjection.

April 25, 2011

Menactra approved for use in infants, toddlers

The Food and Drug Administration has approved the first vaccine for preventing meningococcal disease in children as young as 9 months old, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved the first vaccine for preventing meningococcal disease in children as young as 9 months old, the agency said.

The FDA announced the approval of Menactra, made by Sanofi Pasteur, the vaccines arm of French drug maker Sanofi-Aventis. Meningococcal disease is a life-threatening illness caused by Neisseria meningitidis bacteria that infect the bloodstream and the lining surrounding the brain and spinal cord.

April 21, 2011

Merck, Sanofi commence late-stage trial for childhood diseases vaccine

Merck and Sanofi Pasteur have started a late-stage clinical trial of a combination vaccine for six childhood diseases, the companies said Thursday.

WHITEHOUSE STATION, N.J. — Merck and Sanofi Pasteur have started a late-stage clinical trial of a combination vaccine for six childhood diseases, the companies said Thursday.

February 3, 2011

Chauncey Billups tapped as Vaccines for Teens spokesman

Chauncey Billups, point guard for the NBA's Denver Nuggets team, was named the latest spokesman for a national multimedia campaign designed to educate preteens, teens and their parents about the importance of vaccination against serious, potentially life-threatening diseases.

NEW YORK — Chauncey Billups, point guard for the NBA's Denver Nuggets team, was named the latest spokesman for a national multimedia campaign designed to educate preteens, teens and their parents about the importance of vaccination against serious, potentially life-threatening diseases.

As the latest spokesman for Vaccine for Teens, Billups will be featured in a new public service announcement, which will air on NBA media and network/cable game broadcasts.

October 10, 2010

Drug makers fight infectious diseases with 400 drugs in pipeline

Humanity has come a long way since the days when people thought sickness came from...

September 12, 2010

FDA accepts approval application for Fluzone Intradermal

The Food and Drug Administration has accepted a regulatory approval application for a flu vaccine...

SWIFTWATER, Pa. The Food and Drug Administration has accepted a regulatory approval application for a flu vaccine administered in the skin.

Sanofi Pasteur, the vaccines arm of French drug maker Sanofi-Aventis, announced Monday that the FDA had accepted its application for Fluzone Intradermal (influenza virus vaccine). The company expects the FDA to take action on the vaccine in the first half of next year.

August 25, 2010

FDA gives Sanofi Pasteur the OK to expand use of Menactra vaccine

The Food and Drug Administration has accepted an application from Sanofi Pasteur to expand the...

SWIFTWATER, Pa. The Food and Drug Administration has accepted an application from Sanofi Pasteur to expand the use of a vaccine in children.

Sanofi Pasteur, the vaccines division of French drug maker Sanofi-Aventis, announced Thursday the FDA’s acceptance of its application seeking approval of Menactra (meningococcal [groups A, C, Y and W-135] polysaccharide diphtheria toxoid conjugate vaccine) for active immunizations of infants and toddlers against invasive meningococcal disease.